what are glp 1 oral medications Pills vs. Pens: The Ultimate Comparison of and Injectable GLP-1s Oral GLP-1 Therapy for Obesity

In the tirzepatide trial, participants lost an average of 6.9% of their weight after 12 weeks, while retatrutide participants lost 7.2% at the lowest dose after 24 weeks

Insurance coverage only potentially applies to medication costs, not membership or support services

In terms of appeal, almost half of US GLP-1 users (45%) express some switching preference: for lighter or better-for-you versions of beer and wine, for zero- or low-alcohol versions of their favourites, or for premium quality versions of their favourite drinks now that less is more. Callum Saunders, planning director at brand activation agency Zeal, which works with global brands including Nestl, Carlsberg, and Britvic, is equally upbeat

When a medication comes off patent, cheaper generics/biosimilars tend to come to market

Research examining metabolic benefits of GLP-1 receptor agonists in patients with coexisting type 2 diabetes and autoimmune thyroid disease has shown that these medications remain effective for glycemic control and weight management in this population